299 - Diagnosis and Management of Cryptococcal Meningitis

10/5/2019

3:15 PM - 4:30 PM

Room: Walter E. Washington Convention Center, Ballroom ABC (3rd Floor)

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-427-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the advances in the treatment of cryptococcal meningitis
describe the epidemiology and clinical manifestations of cryptococcal meningitis
explain the rationale for timing of intitiating antiretroviral therapy in AIDS-associated cryptococcosis

Presentations:

3:15 PM - 3:40 PM
2858 - Epidemiology, Clinical Manifestations, and Prognosis of Cryptococcal Meningitis
Nina Singh, MD – VA Medical Center
3:40 PM - 4:05 PM
2859 - Advances in Antifungal Therapy of Cryptococcal Infections
Olivier Lortholary, MD – Hosp Avicenne
4:05 PM - 4:30 PM
2860 - HIV Therapy and Cryptococcosis: When to Start, What to Start With, and How to Manage IRIS
David R. Boulware, MD, MPH, CTropMed, FIDSA – University of Minnesota

Moderator(s)

Jose M. Miro, MD, PHD

Senior Consultant / Professor of Medicine
Hosp Clinic - IDIBAPS - Univ. of Barcelona. Barcelona, Spain
Barcelona, Spain

Disclosure: AbbVie, Angelini, Contrafect, Cubist, Genentech, Gilead Sciences, Jansen, Medtronic, MSD, Novartis, Pfizer, and ViiV Healthcare: Advisory Board, Research Grant
PW

Peter Williamson, MD, PHD

Chief, Translational Mycology Section
National Institute of Allergy and Infectious Diseases
Bethesda, MD

Disclosure: Nothing to disclose

Speaker(s)

David Boulware, MD, MPH, CTropMed, FIDSA

Professor
University of Minnesota
Minneapolis, MN

Disclosure: Gilead Sciences, Inc.: Research Grant
OL

Olivier Lortholary, MD

Hosp Avicenne
Bobigny, France
NS

Nina Singh, MD

VA Medical Center
Pittsburgh, PA

Disclosure: Nothing to disclose